Intel (INTC) started 2026 at $36.90. By early June, the stock trades near $130, a gain of roughly 250% in five months.
That is the kind of move that forces every investor to ask the same question. Is this a real turnaround, or a crowded short squeeze waiting to unwind?
The answer matters because Intel is no longer a quiet legacy chip story. It is now a US government-backed AI foundry contender, and its results will shape how the entire American semiconductor stack competes against TSMC.
Three catalysts stacked on top of each other since January. First, Intel locked in expanded CHIPS Act grants tied to its Ohio and Arizona fabs. The funding de-risked capex through 2027 and removed the dilution overhang that crushed shares in 2024.
Second, Intel disclosed an Apple foundry deal in mid-May. Apple will produce a portion of its custom silicon on the Intel 18A process node. That single contract validated the foundry pivot in a way that years of management commentary could not.
Third, AI server CPU demand surfaced faster than expected. Intel Xeon 6 chips paired with Nvidia (NVDA) GPUs are now a default rack configuration at several hyperscalers. According to Reuters, AI-linked revenue now contributes around 60% of Intel's quarterly sales mix, up from less than 25% a year ago.
The bull case rests on customer concentration moving in Intel's favor. Microsoft (MSFT) signed a multi-year 18A wafer agreement in February. AWS expanded its Xeon footprint for inference workloads in April, citing better power efficiency than the prior generation.
The US Department of Defense is the quiet anchor of the thesis. Intel is the only American-owned leading-edge foundry. That status gives it priority access to defense and intelligence chip orders that cannot legally ship to Taiwan Semiconductor (TSM) under current export rules.
According to CNBC, Intel's foundry backlog now exceeds $15 billion in committed wafer starts through 2027. Roughly a third of that figure is tied to government and defense customers.
None of these contracts have shipped at full volume. Execution risk on 18A yields remains the single biggest unknown. A six-month yield slip would push margin recovery into 2028 and likely force Intel to renegotiate pricing with Apple and Microsoft.
Intel's gross margin bottomed near 35% in Q4 2025. Management has guided to a return to 50% by late 2027. The path depends on three things working at the same time.
Foundry utilization needs to clear 70% on 18A. Product mix needs to shift toward higher-ASP AI server chips. Operating expenses need to stay flat in dollar terms while revenue grows by double digits.
Consensus models now price in a 48% gross margin by Q4 2027. That is roughly in line with management guidance but leaves no cushion for execution slips. Any yield disappointment in 2026 likely pushes the target to 2028.
Free cash flow is the second watch item. Intel is still burning roughly $3 billion per quarter on fab buildout. Cash flow positivity is not expected until late 2026 at the earliest.
At $130, Intel trades around 28 times forward 2027 earnings. That is below AMD (AMD) at 35 times and below TSM at 24 times when adjusted for foundry growth rate.
On a price-to-book basis, Intel is the cheapest of the three at 3.1 times. AMD trades at 4.8 times. TSM trades at 6.2 times. The book-value gap reflects Intel's enormous fab asset base, which the market historically discounted as low-return capital.
The valuation gap exists because the market has not fully priced 18A execution success. If Intel hits its 2027 margin target, the stock could rerate to 35 times forward earnings. That implies meaningful upside even from current levels.
Short interest peaked at 8% of float in February. It now sits near 2%. Most of the squeeze fuel has already burned off, which means the next leg up must come from fundamentals, not forced covering. That is a healthier setup for buyers entering today.
Intel's 250% rally is mostly real, but the easy gains are behind us. The Apple deal and CHIPS Act funding are durable catalysts. The remaining upside depends on 18A yields and margin recovery actually landing in 2027 as guided.
For investors deciding between Hold, Add, and Trim, the framework is simple. Add on weakness if you believe 18A ships on schedule. Hold if you want to wait for Q3 2026 earnings to confirm AI revenue mix. Trim if you took a 200% gain and need to rebalance position size. Trade US stocks from $1 to scale into INTC without committing a full share.
Is Intel still a buy at $130?
The valuation is reasonable if 18A yields hit guidance. Below 50% gross margin by late 2027, the stock looks expensive. Above it, INTC has room to run further from here.
How does Intel compare to AMD and Nvidia right now?
Intel is the foundry play with US government tailwinds. AMD is the data center CPU and GPU challenger. Nvidia is the AI accelerator leader. Each ticker solves a different portfolio need.
What is the biggest risk to the Intel thesis?
18A yield disappointment is the top risk. A six-month delay would push margin recovery into 2028 and likely trigger a 25% to 30% drawdown from current levels.
Does the Apple foundry deal really matter?
Yes. It validates 18A as competitive with TSMC's leading nodes. It also brings recurring high-volume revenue that smooths foundry utilization through 2027 and beyond. That predictability is what most foundry investors pay a premium for in any cycle.
Disclaimer
Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA). This content is for educational purposes only and does not constitute financial advice. Always do your own research (DYOR) before investing.
